As a result, since AChE inhibition is an important task in the treatment of Alzheimer’s disease, these compounds may have an interesting future for the development of new drugs to neurodegenerative disorders. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.